Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma.
Kaposi's sarcoma-associated herpesvirus (KSHV) serologic assays were used to detect specific antibodies to KSHV lytic and latent antigens in 27 patients with multiple myeloma, 27 control patients with other cancers, and 50 random blood donors. Antibodies to KSHV recombinant minor capsid antigen orf65 were found in 81% of patients with multiple myeloma, 22% of control patients with other cancers, and 6% of the blood donors. Antibodies to KSHV latent nuclear antigens were found in 52% of patients with multiple myeloma, 26% of control patients with other cancers, and 2% of the blood donors. All of the 11 patients with progressive multiple myeloma were KSHV-seropositive. Antibodies to Epstein-Barr virus nuclear antigen 1 were present in 89% of patients with multiple myeloma, 93% of control patients with other cancers, and 88% of the blood donors. These data support the possible association of KSHV infection with multiple myeloma, particularly with progressive disease.
Gao
S J
SJ
Department of Pediatrics, University of Texas Health Science Center at San Antonio, USA. gaos@uthscsa.edu
Alsina
M
M
Deng
J H
JH
Harrison
C R
CR
Montalvo
E A
EA
Leach
C T
CT
Roodman
G D
GD
Jenson
H B
HB
D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000276:immunology; D019288:Herpesvirus 8, Human / Q000276:immunology*; D006801:Humans; D009101:Multiple Myeloma / Q000097:blood / Q000276:immunology / Q000821:virology*; D009687:Nuclear Proteins / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D009687:Nuclear Proteins; C109540:latency-associated nuclear antigen